West Pharmaceutical Services (WST) Research & Development (2009 - 2026)
West Pharmaceutical Services (WST) posted Research & Development of $19.7 million for Q2 2026, up 24.68% sequentially from $15.8 million in Q1 2026, and up 3.14% YoY from $19.1 million in Q2 2025.
West Pharmaceutical Services (WST) Research & Development (2009 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Research & Development for 18 years, with the latest figure at $19.7 million in Q2 2026.
- Quarterly Research & Development rose 3.14% year-over-year to $19.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $74.4 million (up 7.2% YoY) and the FY2025 annual result came in at $74.3 million, up 7.53% from the prior year.
- Research & Development improved to $19.7 million in Q2 2026 per WST's latest filing, from $15.8 million in the prior quarter.
- Over five years, Research & Development peaked at $21.8 million in Q4 2025 and troughed at $13.6 million in Q3 2022.
- A 5-year average of $17.0 million and a median of $16.8 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2025: Research & Development grew 20.59% in 2023, then dropped 7.39% in 2025.
- Over 5 years, Research & Development stood at $15.9 million in 2022, then rose by 15.72% to $18.4 million in 2023, then increased by 0.54% to $18.5 million in 2024, then grew by 17.84% to $21.8 million in 2025, then dropped by 9.63% to $19.7 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $19.7 million, $15.8 million, and $21.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.51 Bn | 127.30 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.76 Bn | 50.90 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.39 Bn | 34.04 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.45 Bn | 31.98 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 28.29 Bn | 25.61 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.92 Bn | 24.49 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.28 Bn | 14.88 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.77 Bn | 14.63 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.51 Bn | 11.36 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Align Technology | 11.35 Bn | 10.25 Bn | 757.43 Mn | 102.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.70 Mn |
| Mar 31, 2026 | 15.80 Mn |
| Dec 31, 2025 | 21.80 Mn |
| Sep 30, 2025 | 17.10 Mn |
| Jun 30, 2025 | 19.10 Mn |
| Mar 31, 2025 | 16.30 Mn |
| Dec 31, 2024 | 18.50 Mn |
| Sep 30, 2024 | 15.50 Mn |
| Jun 30, 2024 | 17.50 Mn |
| Mar 31, 2024 | 17.60 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Sep 30, 2023 | 16.40 Mn |
| Jun 30, 2023 | 16.50 Mn |
| Mar 31, 2023 | 17.10 Mn |
| Dec 31, 2022 | 15.90 Mn |
| Sep 30, 2022 | 13.60 Mn |
| Jun 30, 2022 | 14.40 Mn |
| Mar 31, 2022 | 14.60 Mn |
| Dec 31, 2021 | 13.70 Mn |
| Sep 30, 2021 | 13.10 Mn |